Some reports identify YAP1 expression in 2.8–10% of clinical SCLC samples, while others do not detect significant YAP1 levels in genetically engineered mouse models (GEMMs), patient-derived xenografts (CDXs), or human tumors [14,16,26,31,34]. The gene discussed is YAP1; the disease is small cell lung carcinoma.